Covid-19 vaccination in patients with multiple myeloma: Focus on immune response

Am J Hematol. 2021 Aug 1;96(8):896-900. doi: 10.1002/ajh.26263. Epub 2021 Jun 21.
No abstract available

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging / immunology
  • Antibodies, Neutralizing / biosynthesis
  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral / biosynthesis
  • Antibodies, Viral / immunology
  • Antibody Specificity
  • Antigenic Variation / genetics
  • Antigenic Variation / immunology
  • Antigens, Viral / genetics
  • Antigens, Viral / immunology
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • COVID-19 / complications*
  • COVID-19 / prevention & control
  • COVID-19 Vaccines / immunology*
  • Epitopes / genetics
  • Epitopes / immunology
  • Humans
  • Immunity, Cellular
  • Immunocompromised Host
  • Immunogenicity, Vaccine
  • Immunoglobulin G / biosynthesis
  • Immunoglobulin G / immunology
  • Multiple Myeloma / complications*
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / immunology
  • Mutation
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antigens, Viral
  • Antineoplastic Agents
  • COVID-19 Vaccines
  • Epitopes
  • Immunoglobulin G